Katherine Adams focuses her practice on intellectual property and patent litigation in the life sciences and pharmaceutical arts. Registered to practice before the U.S. Patent and Trademark Office, Katherine has represented clients in trials in federal district courts, contested proceedings at the Patent Trial and Appeal Board (PTAB) including post-grant reviews (PGRs) and inter partes reviews (IPRs), appellate cases at the U.S. Court of Appeals for the Federal Circuit, and Section 337 investigations before the International Trade Commission (ITC).
In addition to litigation, Katherine provides patent portfolio counseling and guidance on transactional matters. She has performed due diligence for mergers and acquisitions, including ownership, freedom to operate, and patentability analyses. Her experience covers a broad range of areas and technologies, including cancer, rare genetic disorders, chronic pain, urinary symptoms, nutraceuticals, hemophilia, neutropenia, immunotherapies, and mRNA vaccines, among others.